Clinical Research Directory
Browse clinical research sites, groups, and studies.
Idiopathic Pulmonary Fibrosis Cohort of TCM
Sponsor: Henan University of Traditional Chinese Medicine
Summary
This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targets, and provides references for precision traditional Chinese medicine treatment.
Official title: Idiopathic Pulmonary Fibrosis Cohort Studies of Chinese Medicine
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-09-05
Completion Date
2028-11-30
Last Updated
2025-09-09
Healthy Volunteers
No
Conditions
Interventions
Traditional Chinese medicine (TCM)
Regulated use of Chinese medicine treatment protocols is included as an exposure factor. Exposure is defined as taking the medication continuously for more than 3 months per year, or intermittently for more than 6 months per year. According to the standardised use of TCM protocols, the group is divided into an exposed group (TCM cohort) and an unexposed group (non-TCM cohort).
Non-traditional Chinese medicine (non-TCM)
All intervention measures that do not meet the criteria for TCM exposure are regarded as non-TCM exposure.
Locations (1)
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, China